NMDAR西使:

Nabil Seery1,2, Robb Wesselingh1,2, Paul Beech3,4

  • 1Department of Neuroscience, Monash University, Melbourne, Australia.

概括

单次服用瑞思西玛的疗程显著降低了抗NMDAR抗体介导脑炎的复发风险. 对于需要重新治疗的患者,六个月后的Rituximab会延迟复发,但这种效果会在12个月后减弱.